BRCA2 and breast carcinoma: ○ Women with a pathogenic mutation of the BRCA2 gene or other genes at moderate or high risk for breast cancer, in addition to those not tested but with first-degree relatives who are carriers should undergo mammographyannually after the diagnosis of the mutation (not before age of 30)(Category A).